Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system

Cancer

Volumn 122, Issue 3, 2016, Pages 456-463

  Singal, Amit G ^a,b,c   Gupta, Samir ^d,e   Tiro, Jasmin A ^c   Skinner, Celette Sugg ^c   McCallister, Katharine ^c   Sanders, Joanne M ^c   Bishop, Wendy Pechero ^c   Agrawal, Deepak ^a   Mayorga, Christian A ^a   Ahn, Chul ^c   Loewen, Adam C ^c   Santini, Noel O ^b   Halm, Ethan A ^a,b,c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

colonoscopy; colorectal cancer screening; fecal immunochemical test; navigation; randomized controlled trial; safety net health system

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FECAL IMMUNOCHEMICAL TEST; FEMALE; FOLLOW UP; HOME DIAGNOSTIC TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNDERSERVED; MIDDLE AGED; OCCULT BLOOD TEST; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; AGED; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; PRIMARY PREVENTION; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PRIMARY PREVENTION;

EID: 84949292754     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29770     Document Type: Article

References (26)

1. Siegel R, Naishadham D, Jemal A., Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
3. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
4. Gupta S, Sussman DA, Doubeni CA, et al., Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014; 106: dju032.
5. Lieberman DA, De Garmo PL, Fleischer DE, Eisen GM, Helfand M., Patterns of endoscopy use in the United States. Gastroenterology. 2000; 118: 619-624.
6. Rex DK., Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol. 1995; 90: 353-365.
7. Elmunzer BJ, Singal AG, Sussman JB, et al., Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc. 2015; 81: 700-709.e3.
8. Gupta S, Halm EA, Rockey DC, et al., Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013; 173: 1725-1732.
9. Inadomi JM, Vijan S, Janz NK, et al., Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012; 172: 575-582.
10. Willis GB., Cognitive interviewing: A "how-to" guide. Research Triangle Park, NC: Research Triangle Institute. 1999. Available at: http://appliedresearch.cancer.gov/archive/cognitive/interview.pdf. Accessed October 27, 2015.
11. Quintero E, Castells A, Bujanda L, et al,; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012; 366: 697-706.
12. Seeff LC, Manninen DL, Dong FB, et al., Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004; 127: 1661-1669.
13. van der Steen A, Knudsen AB, van Hees F, et al., Optimal colorectal cancer screening in states' low-income, uninsured populations-the case of South Carolina. Health Serv Res. 2015; 50: 768-789.
14. Lasser KE, Murillo J, Lisboa S, et al., Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011; 171: 906-912.
15. Percac-Lima S, Grant RW, Green AR, et al., A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009; 24: 211-217.
16. Amri R, Stronks K, Bordeianou LG, Sylla P, Berger DL., Gender and ethnic disparities in colon cancer presentation and outcomes in a US universal health care setting. J Surg Oncol. 2014; 109: 645-651.
17. Laryea JA, Siegel E, Klimberg S., Racial disparity in colorectal cancer: the role of equal treatment. Dis Colon Rectum. 2014; 57: 295-302.
18. Siegel R, Desantis C, Jemal A., Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117.
19. Singal AG, Gupta S, Lee J, et al., Importance of determining indication for colonoscopy: implications for practice and policy original. Clin Gastroenterol Hepatol. 2014; 12: 1958-1963.e1-3.
20. Tiro JA, Kamineni A, Levin TR, et al., The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1147-1158.
21. Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM., Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol. 2010; 25: 1661-1667.
22. Liss DT, Petit-Homme A, Feinglass J, Buchanan DR, Baker DW., Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health. 2013; 38: 829-833.
23. Parente F, Boemo C, Ardizzoia A, et al., Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy. 2013; 45: 27-34.
24. Jimbo M, Myers RE, Meyer B, et al., Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009; 7: 11-16.
25. Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M., Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011; 26: 691-697.
26. Rao SK, Schilling TF, Sequist TD., Challenges in the management of positive fecal occult blood tests. J Gen Intern Med. 2009; 24: 356-360.